[Chromomycosis. Treatment with a combination of thiabendazole and 5-fluorocytosine, 6-year follow-up].
The results of the treatment of 30 cases of chromomycosis (fonsecal pedrosoi) with Thiabendazole (1 g.) and 5. Fluorocytosine (4 g.) are reported. The medium rate of healing was 7,63 months. This treatment was effective in 25 of 30 cases (83 por 100) and ono-effective in 3 (10 por 100). In 2 cases recurrences occurred (6,66 por 100).
D000328:Adult; D000368:Aged; D000382:Agricultural Workers' Diseases / Q000188:drug therapy; D002862:Chromoblastomycosis / Q000188:drug therapy*; D003596:Cytosine / Q000031:analogs & derivatives*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D005437:Flucytosine / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D013827:Thiabendazole / Q000008:administration & dosage / Q000627:therapeutic use*
D003596:Cytosine; D005437:Flucytosine; D013827:Thiabendazole
Cromomicosis. Tratamiento con la asociación thiabendazole y 5-fluorocitosina, seis años de seguimiento.